https://lt.prisysbiotech.com/ Ne - Žmogus Primatas Tyrimai Platforma & CRO | PRISYS Biotech https://lt.prisysbiotech.com/uploads/39406/logo.png https://lt.prisysbiotech.com/translation-research/ Vertimų tyrimai https://lt.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://lt.prisysbiotech.com/nhp-pharmacology/ NHP farmakologija https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://lt.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://lt.prisysbiotech.com/safety-evaluation/ Saugos įvertinimas https://lt.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://lt.prisysbiotech.com/biosafety-research/ Biologinės saugos tyrimai https://lt.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://lt.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://lt.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://lt.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://lt.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://lt.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://lt.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://lt.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://lt.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://lt.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://lt.prisysbiotech.com/pk-pd-adme/adme.html ADME https://lt.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://lt.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://lt.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://lt.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://lt.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://lt.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://lt.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://lt.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://lt.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://lt.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://lt.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://lt.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://lt.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://lt.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://lt.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://lt.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://lt.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://lt.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://lt.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://lt.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://lt.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://lt.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://lt.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://lt.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://lt.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://lt.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://lt.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://lt.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://lt.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://lt.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://lt.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://lt.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://lt.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://lt.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://lt.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://lt.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://lt.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://lt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://lt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://lt.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://lt.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://lt.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://lt.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://lt.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://lt.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://lt.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://lt.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://lt.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://lt.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://lt.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://lt.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://lt.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://lt.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://lt.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://lt.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://lt.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://lt.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://lt.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://lt.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://lt.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://lt.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://lt.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://lt.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://lt.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://lt.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://lt.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://lt.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://lt.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://lt.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://lt.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://lt.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://lt.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://lt.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://lt.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://lt.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://lt.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://lt.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://lt.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://lt.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://lt.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://lt.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://lt.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://lt.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://lt.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://lt.prisysbiotech.com/translation-research/clinical-imaging.html Klinikinis vaizdavimas https://lt.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Klinikinis vaizdavimas https://lt.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://lt.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://lt.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://lt.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://lt.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://lt.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://lt.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://lt.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://lt.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://lt.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://lt.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://lt.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://lt.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://lt.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://lt.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://lt.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://lt.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://lt.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://lt.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://lt.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://lt.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://lt.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2 tipo cukrinio diabeto modelis https://lt.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png 2 tipo cukrinio diabeto modelis https://lt.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://lt.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://lt.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://lt.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://lt.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://lt.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://lt.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://lt.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://lt.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://lt.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://lt.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://lt.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://lt.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://lt.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://lt.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://lt.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://lt.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://lt.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://lt.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://lt.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://lt.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://lt.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://lt.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://lt.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://lt.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://lt.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://lt.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://lt.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://lt.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://lt.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://lt.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://lt.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://lt.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://lt.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://lt.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://lt.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://lt.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://lt.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://lt.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://lt.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://lt.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://lt.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://lt.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://lt.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://lt.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://lt.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://lt.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://lt.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://lt.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://lt.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://lt.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://lt.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://lt.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://lt.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://lt.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://lt.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://lt.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003141532836864.html Molekulinis vaizdavimas NHP modeliuose, skirtuose transliaciniam vaistų kūrimui https://lt.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://lt.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17969188245808128.html „NHP BehaviorAtlas“ internetinis seminaras|3D NHP elgesio stebėjimas, skirtas vaistų vystymuisi https://lt.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://lt.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724242747237376.html 2025 m. santrauka: kaip Prisys iš naujo apibrėžia vertimo patikimumą atliekant NHP tyrimus https://lt.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://lt.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17557518233199616.html NHP - pagrįstas farmakologija ir farmakodinaminės paslaugos|„Prisys Biotech“ https://lt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://lt.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530015070118912.html Susipažinkite su „Prisys Biotech“ artėjančiame ES Roadshow: 2025 https://lt.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://lt.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17451759440602112.html „Prisys Biotech“-2025 m. Vidutinės metų peržiūra https://lt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://lt.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17246798115349504.html Susipažinkite https://lt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://lt.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84040154.html PRISYS 2024 m. metinė ataskaita: NHP modelių tobulinimas ir ikiklinikiniai tyrimai https://lt.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://lt.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77734360.html Prisys Biotech 2024 Q2 informacinis biuletenis – patobulinti ikiklinikiniai CNS terapijos tyrimai su PRISYS kryžmiškai reaguojančiais modeliais https://lt.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://lt.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028064717956096.html Kodėl gyvūnų modeliai sėkmingi arba nesėkmingi kuriant vaistus? https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021151648343040.html Kiekybinis PET tikslinis įsitraukimas į NHP dėl CNS vaistų https://lt.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://lt.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015173539816448.html Nuo vaizdo įrašo iki duomenų: 3D AI stebėjimas, skirtas NHP elgesiui https://lt.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://lt.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015261314720768.html PET biologinio pasiskirstymo vaizdavimas ne{0}}žmoginiuose primatuose https://lt.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://lt.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003140995867648.html PBPK vs. Skyriai modeliai: kodėl PBPK svarbu https://lt.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://lt.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993066962887680.html Webinaro santrauka: verčiamojo NHP tyrimo tobulinimas naudojant skaitmeninį elgesio fenotipą https://lt.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://lt.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990323237086208.html PK biomarkeriai ikiklinikinėje vaistų kūrime|Poveikis – atsakas ir PK/PD https://lt.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://lt.prisysbiotech.com/news/behavior-in-rhesus-17984361915048960.html Spontaniškas savęs{0}}Žalingas elgesys rezuso makakose: Transliacinis NHP modelis neuropsichiatrinių vaistų kūrimui https://lt.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://lt.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17984370091598848.html MIDD ir NHP veiksmingumo modeliai verčiantiesiems vaistų kūrimą https://lt.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://lt.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17975164482118656.html AI-Pagalba 3D NHP elgesio analizė|Elgesio fenotipų nustatymas be žymenų https://lt.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://lt.prisysbiotech.com/news/webinar-nhp-behavioratlas-17975164489835520.html Pasaulinis internetinis seminaras|Sudėtingo NHP elgesio kiekybinis įvertinimas: NHP elgsenos atlaso pristatymas, skirtas aukštos{0}}3D elgsenos fenotipų nustatymui https://lt.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://lt.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17969187453215744.html AI-Pagalba NHP elgesio analizė, skirta ikiklinikiniam vaistų kūrimui|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://lt.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17975164731728896.html Kada pradėti NHP tyrimus autoimuninių vaistų kūrimo srityje https://lt.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://lt.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17975164958041088.html NHP IBD modeliai: ko lėtinis enterokolitas rezuso makakose moko mus apie žarnyno uždegimą https://lt.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://lt.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17975164711805952.html MRT{0}}Nurodomas AAV pristatymas naudojant NHP smegenų modelius, skirtus CNS genų terapijai https://lt.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://lt.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17975164538577920.html Kodėl autoimuninių ligų modeliuose svarbūs teigiami kontrolės vaistai|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://lt.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17975164326077440.html Pradinis ADA patikrinimas išplautose{0}}beždžionėse ikiklinikiniams biologijos tyrimams https://lt.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://lt.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17969187553190912.html Skausmo mechanizmai: UVB saulės nudegimo modelis yra gyvybiškai svarbus vertimo įrankis https://lt.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://lt.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17969188180796416.html Motinos riebios{0}}dietos ir vaikų nutukimo programavimo NHP modeliai https://lt.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://lt.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17942660268352512.html Šunų ir nežmoginių primatų klinikinės patologijos aiškinimas ikiklinikinių tyrimų metu https://lt.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://lt.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17942645048927232.html Molekulinio vaizdavimo biomarkeriai: verčiamieji tyrimai ir vaistų kūrimas https://lt.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://lt.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17942645037491200.html Kas yra netiesinė farmakokinetika? Mechanizmai, charakteristikos ir pasekmės vaistų kūrimui https://lt.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://lt.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17942645109548032.html Kodėl NHP molekulinis vaizdavimas yra labai svarbus transliaciniams PET tyrimams https://lt.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://lt.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17942645144200192.html Kas yra molekulinis vaizdavimas ir kodėl jis svarbus kuriant vaistus? https://lt.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://lt.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17942645192205312.html NHP radionuklidų biologinio pasiskirstymo tyrimai: molekulinis vaizdavimas, skirtas transliaciniam vaistų kūrimui https://lt.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://lt.prisysbiotech.com/news/nhp-heart-failure-model-17942645022270464.html NHP širdies nepakankamumo modelis palaiko transliacinius telomerų atkūrimo genų terapijos tyrimus https://lt.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://lt.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17942645105533952.html Kaip DSA ir CTA vaizdavimas pagerina širdies ir kraujagyslių ligų vaistų saugos vertinimą https://lt.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://lt.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17942645023450112.html NHP arterioveninio šunto trombozės modelis Cynomolgus beždžionėms, skirtas transliaciniam antitrombozinių vaistų įvertinimui https://lt.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://lt.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888352355279872.html Farmakokinetikos duomenys kaip transliacinis biomarkeris https://lt.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://lt.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888352356738048.html Ne{0}}žmogaus primatų plaučių fibrozės modeliai: gerinamas vertimo tikslumas kuriant kvėpavimo takų vaistus https://lt.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://lt.prisysbiotech.com/news/nhp-models-translational-drug-development-17888352448783360.html Kodėl vaistų kūrimas vis labiau priklauso nuo NHP modelių|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://lt.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888352777233408.html PK duomenys kaip farmakodinaminis biomarkeris: verčiamojo vaistų kūrimo skatinimas per kiekybinę farmakologiją https://lt.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://lt.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17855348819878912.html Ne{0}}GLP farmakologijos studijos, skirtos teisiniam pateikimui: duomenų vientisumas ir laboratoriniai reikalavimai https://lt.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://lt.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17855348414178304.html Strateginis neklinikinių farmakokinetinių tyrimų planas: nuo ADME profiliavimo iki vertimo sprendimų{0}} https://lt.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://lt.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17855348522427392.html NHP AV{0}}Šunto trombozės modelis vaistų saugos įvertinimui|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://lt.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17855348684678144.html Kas yra netiesinė farmakokinetika? Mechanizmai ir vertimo PK įvertinimas|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://lt.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17855348484105216.html „Prisys Biotech“ palaiko FDA ir CDE patvirtintą UX-GIP001 IND|NHP CNS pristatymo platforma https://img01.v15cdn.com/gallery/4x3/157.webp https://lt.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17855348219700224.html In vivo imuninių ląstelių sekimas ir PET sekimo priemonių kūrimas NHP modeliuose|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://lt.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17855348387357696.html Dopamino transporterio PET vaizdavimas NHP modeliuose|CNS vaizdavimas|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://lt.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17855348222108672.html PET/CT biologinis pasiskirstymas NHP modeliuose, skirtuose CNS vaistų pristatymui|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://lt.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17855348412195840.html Didelė-gyvūnų radioaktyviojo žymėjimo ir in vivo vaizdo gavimo platforma, skirta vaistų kūrimui https://lt.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://lt.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17855348133176320.html Kodėl vaistų kūrimas vis labiau priklauso nuo NHP modelių: esminis primatų vaidmuo transliacinėje medicinoje|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://lt.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17855348135273472.html IPF vaistų kūrimo iššūkiai ir sprendimai|NHP modeliai su CT vaizdavimu ir PFT https://lt.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://lt.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17855348143170560.html AI be žymeklio NHP 3D elgesio analizės sistema, skirta ikiklinikiniams tyrimams https://lt.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://lt.prisysbiotech.com/news/evaluating-dmpk-properties-17855348344726528.html Kandidatinių junginių DMPK savybių įvertinimas ankstyvojo narkotikų atradimo metu|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://lt.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17855348142089216.html MRT{0}}CNS pristatymas pagal NHP modelius|Vertimo IMRI ir CED platforma https://lt.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://lt.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17855348200219648.html NHP CNS biologinio pasiskirstymo tyrimai|Intratekalinis RNR pristatymas|PRISYS Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://lt.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17855348588504064.html Vertimo PK / PD sistema: Cynomolgus Monkey to Human Dose Prediction|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://lt.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724242829681664.html Kai skausmas tampa atmintimi: emociniai lėtinio skausmo veiksniai ir NHP modelio pranašumas|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://lt.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724242673755136.html Kelių-galinių taškų skausmo įvertinimas: analgetinių vaistų kūrimo ateitis https://lt.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://lt.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724242803057664.html Kodėl tiek daug analgetikų nepavyksta atliekant ikiklinikinius tyrimus? Atsakymas slypi tame, kaip mes vertiname skausmą https://lt.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://lt.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724242958230528.html Kraujo mėginių ėmimo laiko taško planavimas farmakokinetikos (PK) tyrimuose|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://lt.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724242840462336.html PK statistika: ne{0}}skyrių analizės (NCA) parametrai ir ikiklinikinis pritaikymas https://lt.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://lt.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724242698986496.html Kodėl ne{0}}žmogaus primatų modeliai yra labai svarbūs CNS oligonukleotidų terapijai https://lt.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://lt.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724242731836416.html Šlapimo rūgšties metabolizmas žmonėms ir beždžionėms: vaistų kūrimo pasekmės https://lt.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://lt.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724242674279424.html Ne{0}}Žmogaus primatų MASH-susijęs kepenų fibrozės modelis|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://lt.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724242787394560.html Kodėl IMRI{0}}Vaistų teikimas smegenims yra būtinas norint tiksliai nustatyti NHP tyrimus https://lt.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://lt.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674838849594368.html AI-Nežymi NHP 3D elgesio analizės sistema|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://lt.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674826400490496.html LPS-Sukelto ūmaus plaučių uždegimo (ALI) NHP modelis|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://lt.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674826331382784.html HDM+SEB-Cynomolgus Monkeys sukelto atopinio dermatito (ATD) modelis https://lt.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://lt.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674826464027648.html Iš vieno- iki kelių-skyrių PK modelių paaiškinimas|NHP farmakokinetika|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://lt.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674826057737216.html Kaip pasirinkti patikimą ikiklinikinį CRO|Pagrindiniai kriterijai biotechnologijų įmonėms|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://lt.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674826228704256.html Vertimas CAR-T: In vitro ekspertizė ir NHP studijų palaikymas – „Prisys Biotech“ https://lt.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://lt.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674826375570432.html Kodėl daugiau nei 90% kandidatų į CNS vaistus nepasiseka klinikinių tyrimų metu? https://lt.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://lt.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674826120684544.html Parkinsono ligos ikiklinikiniai modeliai: Neurotoksino, genetinių ir NHP modelių pasirinkimo vadovas|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://lt.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674826167739392.html Labai{0}}tikslus vaistų pristatymas ir dirbtinis intelektas-pagrįstos NHP vertimo platformos https://lt.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://lt.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625320869127168.html Th17 pagrįsti NHP imunologijos modeliai|Transliaciniai autoimuniniai tyrimai „Prisys Biotech“. https://lt.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://lt.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625321055577088.html AI-Pagrįsta NHP BehaviorAtlas® sistema|3D elgesio analizės platforma|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://lt.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625320927257600.html RFP šablonas NHP tyrimams|Pagreitinti ikiklinikinių tyrimų efektyvumą https://lt.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://lt.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625321934201856.html Cold Allodynia Pain Model Cynomolgus Monkeys|Prisys Biotechnologijos https://lt.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://lt.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625321067881472.html MRT{0}}Vaistų intracerebrinio pristatymo platforma|Prisys Biotech CNS tyrimai https://lt.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://lt.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625321261376512.html NHP kvėpavimo takų ligų modeliai ir vaistų kvėpavimo takų pristatymo platforma|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://lt.prisysbiotech.com/news/nhp-renal-biopsy-17625321084822528.html NHP inkstų biopsijos platformos ir inkstų ligų modeliai|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://lt.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625321156781056.html PK tyrimai ir tikslinis vaistų pristatymas|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://lt.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625320896848896.html „Prisys Biotechnologies“ NHP tyrimų ir AI{0}}pagrįsta elgesio analizės platforma https://lt.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://lt.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625320859214848.html Per nosį-į-smegenis (N2B) tiekimo technologija CNS tyrimams|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://lt.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625321437357056.html SHR-2004: proveržis VTE prevencijos srityje pacientams, sergantiems kiaušidžių vėžiu – Prisys Biotech sėkmės istorija https://lt.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://lt.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538634930398208.html Cynomolgus ir Rhesus beždžionių modeliai|Prisys Biotech ikiklinikinis CRO https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530014845740032.html Idiopatinė plaučių fibrozė (IPF) NHP modelis|„Prisys Biotech“ ikiklinikinis CRO https://lt.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://lt.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530015002387456.html Cynomolgus beždžionių biologinio pasiskirstymo tyrimai|Prisys Biotech ikiklinikinis CRO https://lt.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://lt.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530015128855552.html „Prisys Biotech“ NHP hematologijos ir insulto tyrimų modeliai https://lt.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://lt.prisysbiotech.com/news/the-importance-of-administration-volume-17530014889092096.html Ikiklinikinių tyrimų administravimo apimties svarba|„Prisys Biotech“ https://lt.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://lt.prisysbiotech.com/news/brain-targeted-drug-delivery-17530014904280064.html Smegenys - tikslinė vaisto pristatymas|„Prisys Biotech“ ikiklinikiniai NHP tyrimai https://lt.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://lt.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530014905033728.html ADC vaistų kūrimas|Ikiklinikinių NHP tyrimų vertimo PK/PD sistema https://lt.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://lt.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17498450911405056.html NHP skausmo modeliai transliaciniams vaistų atradimui|„Prisys Biotech“ https://lt.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://lt.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17498450800583680.html Serumas vs. Plazma: optimalios matricos pasirinkimas ikiklinikinei bioanalizei https://lt.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://lt.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17498450896053248.html Ikiklinikinės dozavimo gairės: IV ir PO tūris, PH ir osmoliarumas tiksliam PK NHP ir kitoms rūšims https://lt.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://lt.prisysbiotech.com/news/nhp-copd-model-17498450852766720.html „Prisys“ populiariausi LOPL tyrimų modeliai ir kvėpavimo platformos kompetencija https://lt.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://lt.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17498450619278336.html NHP ūminio kraujavimo modelis: esminė priemonė pagreitinti naujų hematologinių vaistų vystymąsi https://lt.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://lt.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17498450751726592.html „Prutitus“ tyrimai: „Prisys Biotech“ IL-31 sukeltas NHP modelis, skirtas įvertinti anti -ch gydymą https://lt.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://lt.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17451759507956736.html Anti{0}}vaistų antikūnų (ADA) įvertinimo vadovas https://img01.v15cdn.com/gallery/4x3/148.webp https://lt.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17451759443911680.html Kvėpavimo terapijos: Prisys Biotech integruota NHP platforma ikiklinikiniams tyrimams https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17451759578719232.html NHP skausmo modeliai: pagreitinantis analgetikų vaistų vystymasis „Prisys Biotech“ https://lt.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://lt.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17451759344165888.html NHP modelių platformos, skirtos paremti vaistų kūrimą sudėtingose ligose https://lt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://lt.prisysbiotech.com/news/key-considerations-for-dosing-volume-17451760077628416.html Pagrindinės gyvūnų modelių dozavimo tūrio, PH ir formulės svarstymai https://lt.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://lt.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17451759410242560.html Sukurtos egzosomos: revoliucinis vaistų tiekimas CNS sutrikimams – ikiklinikinės įžvalgos iš „Prisys Biotech“ https://img01.v15cdn.com/gallery/4x3/300.webp https://lt.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17451759778817024.html Pagrindiniai gyvūnų rūšių atrankos principai atliekant nukleorūgščių vaistų toksikologijos tyrimus https://img01.v15cdn.com/gallery/4x3/148.webp https://lt.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17451759440389120.html Prisys Biotech DSA ir IMRI hematologiniams, kraujagyslių ir inkstų ligų tyrimams https://lt.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://lt.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17451759277351936.html Cynomolgus beždžionių skausmo modeliai: verčiamieji tyrimai, skirti proveržio jonų kanalų terapijai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17451759495717888.html Pažanga atopinis dermatito tyrimas: „Prisys Biotech“ ne žmogaus primatų (NHP) modelis https://lt.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://lt.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17451759472059392.html „Prisys Biotech“ NHP atopinis dermatito modelis, skirtas anti-produktų vystymuisi https://lt.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://lt.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17388198424536064.html Tyrimų su gyvūnais kūrimas: pagrindiniai dalykai, siekiant ikiklinikinių tyrimų sėkmės https://img01.v15cdn.com/gallery/4x3/300.webp https://lt.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17388198306948096.html Atopinis dermatitas: kaip cynomolgus beždžionių modeliai modeliuoja tikslią terapiją https://lt.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://lt.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17388198177793024.html Astmos tyrimai: kodėl ne{0}}žmogaus primatų modeliai yra labai svarbūs kuriant naujus vaistus https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17388231096427520.html Antisense oligonukleotido (ASO) farmakokinetikos supratimas: pagrindiniai absorbcijos ir pasiskirstymo veiksniai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17388198425601024.html NHP įkvėpimo tyrimai biologiniams tyrimams: PRISYS specializuotos ikiklinikinės CRO paslaugos https://img01.v15cdn.com/gallery/4x3/300.webp https://lt.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17388198216131584.html Išplėstiniai ikiklinikiniai įkvėpimo tyrimai: „Prisys Biotech“ techninės galimybės ir patirtis https://img01.v15cdn.com/gallery/4x3/300.webp https://lt.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17388198600139776.html Farmakokinetikos (PK) supratimas: Pagrindiniai parametrai ir taikymas kuriant vaistus https://lt.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://lt.prisysbiotech.com/news/intracerebroventricular-icv-injection-17388198312403968.html Intracerebroventrikulinė (ICV) injekcija: tikslus CNS įvedimas ikiklinikiniams tyrimams https://lt.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://lt.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17388198223242240.html Intracerebrinė (ICM) injekcija: tikslus CNS terapijos taikymas – ikiklinikiniai svarstymai https://img01.v15cdn.com/gallery/4x3/148.webp https://lt.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17388198357574656.html Intratekalinė (IT) injekcija: tiesioginis CNS įvedimo būdas pažangiajai terapijai – ikiklinikiniai svarstymai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17388198181430272.html Parkinsono ligos tyrimų tobulinimas naudojant NHP modelį https://img01.v15cdn.com/gallery/4x3/300.webp https://lt.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17388198480782336.html Ikiklinikiniai PK/PD tyrimai ir NHP vaistų kūrimo modeliai|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://lt.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17313391144788992.html Taikymas į interleukiną-31 (IL-31): naujas autoimuninių ligų vaistų kūrimo ribas – Prisys Biotech NHP modeliai ikiklinikiniams tyrimams https://lt.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://lt.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17302933400445952.html Neklinikinis imunotoksiškumo įvertinimas: strategija, pagrindiniai aspektai ir metodo pasirinkimas https://img01.v15cdn.com/gallery/4x3/232.webp https://lt.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17302933222499328.html Mikrobų tyrimai ir jų poveikis ne{0}}žmoginiams primatams atliekant ikiklinikinius DMPK tyrimus https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17302933336122368.html Cynomolgus beždžionių endometriozės modelis, siekiant patobulinti terapinius tyrimus https://lt.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://lt.prisysbiotech.com/news/membranous-nephropathy-model-17302933206475776.html Membraninės nefropatijos (MN) vaistų kūrimas: Prisys Biotech Cynomolgus Monkey modelių platforma https://img01.v15cdn.com/gallery/4x3/148.webp https://lt.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17302969191080960.html Inhaliuojamų vaistų farmakokinetika: paradigmos pokytis nuo sisteminio poveikio į plaučius https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/animal-models-for-womens-health-17302933142217728.html „Prisys Biotech“: gyvūnų modeliai, skirti moterų sveikatos terapijai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17302933459854336.html Pasaulinė nutukimo diena|„Prisys Biotech“ NHP Metaboliniai modeliai: naujos kartos kovos su panaudojimo terapijos kūrimo sukūrimas https://lt.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://lt.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17302933212980224.html „Prisys Biotech“ Cynomolgus beždžionių psoriazės modelis: Ikiklinikinio farmakodinamikos įvertinimas https://lt.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://lt.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17302933114332160.html Farmakokinetikos ir farmakodinamikos integracija kuriant vaistus https://lt.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://lt.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888352320398336.html Internetinis seminaras pagal-paklausą|Tikslus tiltas: MRT{1}}CED ir verčiami NHP modeliai, skirti CNS vaistų pristatymui https://lt.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://lt.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17302969032467456.html Ką iš tikrųjų patvirtina vaistų kūrimo koncepcijos įrodymas (PoC)? https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17302933130339328.html Gyvūnų modeliai|Skausmo modelio kūrimo iššūkiai ir taikymas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17302933307728896.html Neklinikiniai farmakodinaminiai tyrimai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17246797897212928.html Idealaus ne{0}}žmogaus primato pasirinkimas toksikologijos tyrimams: makakos makakos, rezuso makakos ir marmozetės https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81169054.html Tikslinė Parkinsono ligos terapija: proveržis realiuoju laiku-MRT-valdoma kamieninių ląstelių transplantacija https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17302933142971392.html Sisteminė raudonoji vilkligė (SRV) ir gyvūnų modelių vaidmuo terapinėje raidoje https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17302933201282048.html Nežmogiškasis reumatoidinio artrito (RA) primatų modelis https://lt.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://lt.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17302933217747968.html Gyvūnų smegenų stereotaksiniai instrumentai, pagrįsti 3D koordinačių sistemomis https://lt.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://lt.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17302934428607488.html Gyvūnų modeliai, skirti bandymams in vivo (1): nustatymas ir klasifikavimas https://img01.v15cdn.com/gallery/4x3/148.webp https://lt.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84040146.html Galimi biologinių medžiagų patekimo į smegenis keliai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84040228.html Reumatoidinio artrito (RA) tyrimų tobulinimas naudojant nežmoginių primatų modelius https://lt.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://lt.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84040695.html Atopinio dermatito vaistų veiksmingumo gyvūnų modelių tyrimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84040143.html Svarbus gyvūnų modelių vaidmuo tiriant žmonių ligas https://lt.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://lt.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84040153.html Parkin genų trūkumo beždžionių modelis atskleidžia naujus Parkinsono ligos mechanizmus ir terapinius tikslus https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84040148.html Neklinikinis vaistų kūrimo vadovas: ūmaus, poūmio, poūmio ir lėtinio bendro toksiškumo tyrimai https://lt.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://lt.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84040144.html Novatoriškas vaistų tiekimas iš nosies į smegenis (N2B): kraujo ir smegenų barjero apėjimas https://lt.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://lt.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84040697.html Mini kiaulių, kaip neklinikinės stambių gyvūnų rūšies, galimybės ir iššūkiai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83057124.html Vaistų teikimo nuo smegenų ligų strategijos https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83045840.html Realiuoju laiku-operacinė MRT navigacija: FDA patvirtinimas dėl pirmojo AADC trūkumo genų terapijos https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83040789.html Akių lašų toksiškumo akims tyrimai: vaistų poveikio ir saugos įvertinimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82721620.html Prisys Biotech sukūrė Cynomolgus Monkey psoriazės modelį, kad paspartintų vaistų kūrimą https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82721630.html Prisys Biotech išsamūs ne{0}}žmogaus primatų modeliai inkstų ligų tyrimams https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82721621.html Išsamus ikiklinikinis antikūnų-konjugatų (ADC) saugumo įvertinimas ne-žmoginiuose primatuose https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82721624.html Antikūnų{0}}konjugatų (ADC) farmakokinetikos įvertinimas ne{1}}žmoginiuose primatuose https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82721627.html ADC farmakodinamikos įvertinimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82721625.html ADC narkotikų DMPK supratimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82721632.html Nukleino rūgščių vaistų ir „Prisys Biotech“ tyrimų pajėgumų plėtros pažanga https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395263.html MRNR plaučių pristatymo sistemų ir Prisys biotech naujoviškų paslaugų pažanga https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82721634.html Kodėl 2024 m. Nobelio fiziologijos ar medicinos premija buvo skirta šiems dviem mokslininkams, tyrusiems mikroRNR? https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82724987.html Centrinės nervų sistemos (CNS) vaistų farmakokinetikos (PK) svarstymai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656488.html CNS tyrimų pažanga: Prisys Biotech MRT{0}}suderinama smegenų injekcijos sistema ir CED technologija https://lt.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://lt.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81169056.html Kraujavimo ir krešėjimo terapinių naujovių tobulinimas naudojant Cynomolgus Monkey MCAO modelį https://lt.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://lt.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81169058.html DMPK centrinės nervų sistemos (CNS) vaistų įvertinimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/animal-models-of-human-diseases-81169049.html Žmonių ligų gyvūnų modeliai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81169050.html Skausmo vertinimo naujovės: AI-pagrįsta elgesio analizė https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/china-experimental-monkey-industry-81169051.html Kinijos eksperimentinės beždžionių pramonės istorija, dabartinė padėtis, iššūkiai ir galimybės https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/human-disease-animal-models-81169053.html Žmonių ligų gyvūnų modeliai: svarbi priemonė biomedicininiams tyrimams tobulinti https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81169055.html Ikiklinikinės farmakodinamikos svarba kuriant vaistus|Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://lt.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81169047.html Intranazalinis administravimas gyvūnų tyrimuose https://lt.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://lt.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79424206.html Revoliucija CNS vaistų kūrimui: PRISYS Biotech pristato IMRI technologiją https://lt.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://lt.prisysbiotech.com/news/convection-enhanced-delivery-81169052.html Tiksliosios medicinos tobulinimas: konvekcinė{0}}patobulinto pristatymo (CED) technologija, sukurta Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://lt.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81169048.html Cynomolgus Monkey Chronic Kidney Disease (CKD) modelis Prisys Biotech https://lt.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://lt.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79541137.html Neklinikinis vaistų įvedimo į akis saugumo įvertinimas naudojant Cynomolgus Macaques https://lt.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://lt.prisysbiotech.com/news/compartment-pk-model-81169057.html Farmakokinetikos skyrių ir ne{0}}skyrių modelių supratimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81169046.html Pažangūs CNS pristatymo metodai Cynomolgus Monkeys: paspartinti oligonukleotidų vaistų vystymąsi https://lt.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://lt.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79540227.html Nežmoginių primatų naudojimo mažinimas atliekant neklinikinius saugos vertinimus: FDA ir pramonės perspektyvos https://lt.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://lt.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79537812.html LNP{0}}pagrįstų genų terapijos vaistų LCMS ikiklinikinė bioanalizė https://lt.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://lt.prisysbiotech.com/news/mrna-based-therapies-past-79537810.html MRNA{0}}pagrįstos terapijos: praeitis https://lt.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://lt.prisysbiotech.com/news/pk-strategies-of-pdc-79539411.html Peptidų{0}}vaistų konjugatų (PDC) farmakokinetinių tyrimų strategijos https://lt.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://lt.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79539420.html AAV vaidmuo genų terapijoje: imuninis atsakas ir toksiškumas https://lt.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://lt.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79539419.html Optimizuotos neklinikinio imunogeniškumo vertinimo strategijos https://lt.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://lt.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79537806.html Farmakodinaminis (PD) genų terapijos įvertinimas https://lt.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://lt.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79537815.html Oligonukleotidinių vaistų farmakokinetika ir bioanalizė{0}}(1) https://lt.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://lt.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79537817.html Oligonukleotidinių vaistų farmakokinetika ir bioanalizė: absorbcijos ir plazmos farmakokinetikos (PK) charakteristikos https://lt.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://lt.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79537811.html Veiksniai, į kuriuos reikia atsižvelgti nustatant oligonukleotidinių vaistų imunogeniškumą https://lt.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://lt.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79537816.html MRNA: galingas ir universalus kovos su ligomis įrankis{0}}Prisys-Biotech https://lt.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://lt.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79537808.html Kinijos mokslininkai siūlo naujas strategijas, kaip pakeisti pagrindinius Parkinsono ligos simptomus https://lt.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://lt.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79538748.html Prisys Biotechnology: naujos lipidų nanodalelės, skirtos MRNR pristatymui primatams https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79538740.html Transliacinės medicinos tyrimų svarba nuo pagrindinių tyrimų iki klinikinių tyrimų https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79538754.html Pagrindiniai veiksniai, į kuriuos atsižvelgta atliekant WOE analizę https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79538742.html Kaip pristatyti biologines medžiagas į smegenis? https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79538745.html Kaip vaistai juda ir keičiasi mūsų organizme: trumpas farmakokinetikos įvadas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79540225.html Kaip greičiau ir saugiau sukurti naujus vaistus: ikiklinikinių DMPK tyrimų vadovas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79538750.html Laboratorinių beždžionių laikymo grupėje gairės https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79538746.html Esminis eksperimentinių beždžionių vaidmuo tobulinant mokslinius tyrimus https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79538753.html Macaca Fascicularis (Cynomolgus Monkey) supratimas: pagrindinės charakteristikos ir indėlis į biomedicininius tyrimus https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79538744.html Metabolinių ligų gydymo revoliucija: peptidinių vaistų kūrimo pažanga ir iššūkiai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79538735.html Kaip įvertinti odos gaminių saugumą prieš klinikinius tyrimus? https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79538755.html Reikšmingas eksperimentinių beždžionių vaidmuo kuriant naujoviškus vaistus: žvilgsnis į verslą iš vidaus https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79538752.html Toksiškumas kepenims, kaip pagrindinis susirūpinimas dėl SiRNA vaistų: išsamios analizės tikslo specifiškumas: dviašmenis SiRNR kardas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79538733.html SiRNA terapijos tobulinimas: vaistų kūrimo iššūkių įveikimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79538737.html Genų vaistų, pagrįstų lipidų nanodalelėmis, taikymo perspektyvos https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79538741.html Pagrindiniai dalykai kuriant ne{0}}klinikinių jaunų gyvūnų tyrimų strategijas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79538747.html Nežmoginių primatų (NHP){0}}jutimo ir elgesio ypatybių įžvalga https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79538758.html Neklinikinių tyrimų vertinimo klausimai ir atsakymai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/significance-principles-and-requirements-of-79538760.html Farmakologijos saugos tyrimų reikšmė, principai ir reikalavimai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79538743.html Kaip įvertinti ikiklinikinį farmakologinį veiksmingumą? https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79538734.html Ne{0}}klinikinės farmakologijos tyrimų ir nealkoholinio steatohepatito (NASH) terapinių vaistų įvertinimo apmąstymai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79538738.html CNS ir CGT tyrimų tobulinimas: Prisys Biotechnologies https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79538749.html Ne{0}}žmogaus primatų smegenų skysčių surinkimo gairės https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79538757.html Nežmoginių primatų (NHP) ir šunų klinikinės patologijos duomenų aiškinimo aplinkybės https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79538736.html CNS saugos įvertinimo įtraukimas į bendrosios toksikologijos tyrimus https://lt.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://lt.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79538756.html Kaip atlikti ADC ikiklinikinį farmakologijos / toksikologijos vertinimą? https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79538759.html ADME įžvalgos oligonukleotidiniams vaistams (1) - Absorbcija, pasiskirstymas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79538751.html ADME įžvalgos apie oligonukleotidinius vaistus (2) - Metabolizmas ir išskyrimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79538732.html Ikiklinikiniai gyvūnų tyrimai (1) - Gyvūnų rūšys https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79538739.html Klinikinės patologijos duomenų interpretavimo iššūkiai ir strategijos atliekant ikiklinikinius šunų ir ne{0}}žmoginių primatų tyrimus https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79538761.html Ikiklinikiniai tyrimai su gyvūnais (2) - Vartojimo būdai ir kiekiai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/mrna-based-therapies-present-79537814.html MRNA{0}}pagrįstos terapijos: dabartis https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79537813.html MRNA{0}}pagrįstos terapijos: ateitis ir iššūkiai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79537807.html Trumpas įvadas apie biologinę genų terapijos analizę https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79424207.html Cynomolgus Monkey oftalmologinių vaistų tyrimuose https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79424208.html Vertimo ir kryžminiai{0}}Prisys NHP imunologijos ir uždegimo modelių tyrimai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79200001.html Ne-naivūs NHP ikiklinikiniuose tyrimuose: ekonomiškas-Prisys Biotech sprendimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/nhp-asthma-model-79200000.html NHP astmos modelis: ikiklinikinių vaistų veiksmingumo tyrimų su Prisys Biotech įgalinimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79200617.html Imunologijos ir uždegimo tyrimų tobulinimas naudojant Cynomolgus Macaques modelius - Prisys Biotechnologies https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79199999.html Tiesioginis oligonukleotidinių vaistų tiekimas į CNS ir dažni histopatologiniai pokyčiai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79200002.html Intra{0}}Prisys Biotech smegenų kraujagyslių insulto (ICH) modelis https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75173419.html Ne{0}}klinikiniai farmakodinamikos tyrimai: esminis SiRNR vaistų kūrimo aspektas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77734354.html Magnetinio rezonanso tomografija-Prisys Biotech yra valdoma stambių gyvūnų centrinės nervų sistemos tikslios lokalizacijos ir pristatymo sistema https://lt.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://lt.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77064487.html Inovatyvūs kvėpavimo takų terapijos tobulinimo sprendimai https://lt.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://lt.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74802656.html Prisys: eksperimentų su gyvūnais tobulinimas per Cynomolgus makakų tyrimus https://lt.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://lt.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76183307.html Prisys gavo visišką AAALAC International akreditaciją: svarbus įvykis užtikrinant aukštus laboratorinių gyvūnų priežiūros standartus. https://lt.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://lt.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74680053.html Nukleino rūgščių terapijos tobulinimas naudojant naujausius{0}}prisys biotech nežmoginių primatų modelius https://lt.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://lt.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74177845.html Revoliucinis CNS vaistų pristatymas: Prisys ir intratekalinės injekcijos pažadas https://img01.v15cdn.com/gallery/4x3/148.webp https://lt.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75173416.html Prisys Biotech 2024 Q1 naujienlaiškis - jūsų patikimas nežmoginių primatų tyrimo specialistas https://lt.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://lt.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73590345.html Kaip ultragarsu{0}}valdoma kepenų biopsija pagerina makakų{1}}pagrįstus tyrimus https://lt.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://lt.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73590344.html Nežmoginių primatų naudojimo visą gyvenimą gairės atliekant biomedicininius tyrimus: Prisys biotechnologijos perspektyva https://lt.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://lt.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73022934.html Ne{0}}žmoginiai primatai: trumpas jų biologinių savybių įvadas https://lt.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://lt.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72680595.html Parodos apžvalga|„Prisys Biotech“ šviečia kasmetiniame Amerikos neurologijos draugijos susitikime (SfN 2023) https://lt.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://lt.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72322038.html Susipažinkite su Prisys Biotech Neurologijos draugijos metiniame susirinkime (SfN 2023) https://lt.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://lt.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72322039.html Pasaulinė insulto diena|Dėmesys išeminio insulto gyvūnų modeliams ir farmakologijai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72322036.html „Prisys Biotech“ kviečia jus dalyvauti SAPA-Kinijos metiniame susitikime 2023 m. https://lt.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://lt.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72322040.html Pasaulinė Alzheimerio diena|AD vaistų kūrimo iššūkiai ir sprendimai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72322037.html Prisys Biotech Cynomolgus Makakų gyvūnų modelis padeda kurti naujus antikoaguliantus https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71005383.html Prisys: aukštos{0}}kokybiškos eksperimentų su gyvūnais paslaugos, skirtos naujam XI krešėjimo faktoriaus antikūnui BJTJ-1837 https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71006712.html Hipertrigliceridemijos cynomolgus beždžionių modelio nustatymo metodas ir jo taikymas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71008109.html Farmakologija: pagrindiniai parametrai ir farmakokinetikos (PK) reikšmė https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71005988.html Ikiklinikinis farmakologinis onkolitinio viruso vaistų įvertinimas https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/0-71004899.html Kaip maži nukleorūgščių vaistai gali pakeisti CNS ligų gydymą: Prisys Biotechnology, NHP ligų modelių tiekėjos, įžvalgos https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71005722.html Peptidinių vaistų farmakokinetika, tyrimų strategijos ir atvejų tyrimai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69660903.html Pagrindiniai ADC narkotikų PK tyrimų taškai https://img01.v15cdn.com/gallery/4x3/148.webp https://lt.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69654677.html Prisys Biotechnology: NHP CNS ligų modeliavimo tyrimų platformos lyderė https://lt.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://lt.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309412.html Kaip numesti svorio ir kontroliuoti diabetą naudojant GLP-1 produktus https://lt.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://lt.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309273.html Kaip Kinijos beždžionė padeda efektyviai atlikti ikiklinikinius tyrimus? https://lt.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://lt.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309326.html Koks yra RNAi efektyvumas? https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309261.html „Prisys Biotech“ didelių gyvūnų eksperimentų viešųjų paslaugų platforma: mažos{0}}kainos ir didelio{1}}efektyvumo sprendimas, skirtas eksperimentams su dideliais gyvūnais https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69014610.html Kaip AAV genų terapija gali išgelbėti jūsų regėjimą: naujausi ne{0}}žmogaus primatų studijų pasiekimai https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69013484.html Japonijos toksikologijos draugijos metiniame susitikime „Prisys Biotech“ demonstruoja ne{0}}žmogaus primatų modelių platformą https://lt.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://lt.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69013053.html Daug žadanti AAV genų terapijos ne{0}}žmogiškiems primatams ateitis https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69014674.html Kas yra lipidų nanodalelės genų terapijai? https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69012442.html „Prisys Biotech“ kviečia jus dalyvauti 50-ajame kasmetiniame Japonijos toksikologijos draugijos (JSOT) susirinkime https://lt.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://lt.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69016001.html Imunotoksiškumo testas, vaistų saugos įvertinimas{0}}PRISYS BIOTECH https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68322026.html Optimalus išeminio insulto gyvūnų modelis, nustatytas skaitmeninės atimties angiografijos{0}}vadovaujami autologiniai trombai Cynomolgus Monkeys https://lt.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://lt.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68120221.html Kodėl jums turėtų rūpėti ne{0}}žmoginiai primatai atliekant nukleorūgščių vaistų tiekimo sistemos tyrimus ir plėtrą https://lt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lt.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68120222.html Susipažinkite su Prisys Biotech 70-ajame JALAS 2023 m.! https://lt.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://lt.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68120223.html Genų terapija šviečia naujais retų ligų patvirtinimais https://lt.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://lt.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68120220.html Revoliucinis narkotikų atradimas: kaip nežmoniniai primatai optimizuoja SiRNR atranką, kad gautų greitesnius ir efektyvesnius rezultatus https://lt.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://lt.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67550097.html SiRNR farmakologinio efektyvumo didinimas atliekant nežmoginių primatų tyrimus https://lt.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://lt.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67544524.html Kaip nežmoniniai primatai gali pakeisti SiRNA tyrimus: išsamus vadovas https://lt.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://lt.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67544523.html Pasaulinės laboratorinių gyvūnų dienos minėjimas: kodėl Prisys yra įsipareigojęs skatinti nežmoginių primatų sveikatą https://lt.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://lt.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67550098.html Maksimalus CRISPR/Cas9 tyrimų efektyvumas naudojant nežmoginių primatų modelius https://lt.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://lt.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67558959.html Terapinio potencialo išlaisvinimas: kodėl investicijos į nukleorūgščių vaistus yra medicinos ateitis https://lt.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://lt.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67546963.html Nežmoninių primatų potencialo išlaisvinimas gerinant genų terapijos narkotikų taikinių atradimą https://lt.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://lt.prisysbiotech.com/news/world-parkinsons-disease-day-67549454.html Vienykitės dėl Parkinsono ligos: susikibę rankomis, kad pasaulinė Parkinsono ligos diena būtų informuojama https://lt.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://lt.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67548193.html Kaip efektyviai naudoti ne{0}}žmoginius primatus genų terapijos saugos vertinime https://lt.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://lt.prisysbiotech.com/news/gene-therapy-toxicology-66274533.html Genų terapijos toksikologijos tyrimai su Nonhuam Primate https://lt.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://lt.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66137666.html Išsamus vadovas, kaip atlikti genų terapijos DMPK tyrimą https://lt.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://lt.prisysbiotech.com/news/gene-therapy-nhp-model-66137660.html Revoliuciniai medicininiai tyrimai: genų terapijos proveržis nežmoginių primatų ligų modeliuose! https://lt.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://lt.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66137926.html 10 populiariausių klausimų, susijusių su genų terapija https://lt.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://lt.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66137661.html „Prisys Biotech“: ne{0}}žmogaus primatų farmakologija genų terapijai https://lt.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://lt.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66137659.html Moterų sveikatos palaikymas: žvilgsnis į endometriozę https://lt.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://lt.prisysbiotech.com/news/prisys-sot2023-66137656.html PRISYS ir Taichu Group bendradarbiauja 2023 m. SOT parodoje https://lt.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://lt.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66137658.html Ar mums reikia tolesnių skausmo įvertinimo tyrimų? - NHP https://lt.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://lt.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66138564.html Prisijunkite prie mūsų švęsdami Pasaulinę laukinės gamtos dieną https://lt.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://lt.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66137657.html Prisys Šanchajaus NHP tyrimų ir plėtros centras pradeda veikti, ženklindamas farmacijos tyrimų ir plėtros etapą Kinijoje https://lt.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://lt.prisysbiotech.com/news/meetprisys-sot2023-66137655.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://lt.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg